A detailed history of Mackenzie Financial Corp transactions in Baxter International Inc stock. As of the latest transaction made, Mackenzie Financial Corp holds 124,204 shares of BAX stock, worth $4.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
124,204
Previous 171,441 27.55%
Holding current value
$4.05 Million
Previous $5.73 Million 17.75%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$32.85 - $40.26 $1.55 Million - $1.9 Million
-47,237 Reduced 27.55%
124,204 $4.72 Million
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $404,859 - $536,405
12,317 Added 7.74%
171,441 $5.73 Million
Q1 2024

May 10, 2024

BUY
$37.88 - $43.77 $15,303 - $17,683
404 Added 0.25%
159,124 $6.8 Million
Q4 2023

Jan 30, 2024

BUY
$31.71 - $38.95 $2.28 Million - $2.81 Million
72,035 Added 83.1%
158,720 $6.14 Million
Q3 2023

Oct 25, 2023

BUY
$37.32 - $49.29 $40,007 - $52,838
1,072 Added 1.25%
86,685 $3.27 Million
Q2 2023

Aug 03, 2023

SELL
$39.98 - $47.68 $1.52 Million - $1.81 Million
-37,899 Reduced 30.68%
85,613 $3.9 Million
Q1 2023

Apr 24, 2023

SELL
$37.58 - $52.57 $1.14 Million - $1.6 Million
-30,357 Reduced 19.73%
123,512 $5.01 Million
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $318,875 - $370,267
6,416 Added 4.35%
153,869 $7.84 Million
Q3 2022

Oct 07, 2022

BUY
$53.86 - $66.8 $363,016 - $450,232
6,740 Added 4.79%
147,453 $7.94 Million
Q2 2022

Aug 10, 2022

BUY
$63.83 - $80.0 $1.17 Million - $1.47 Million
18,405 Added 15.05%
140,713 $9.04 Million
Q1 2022

May 13, 2022

BUY
$76.85 - $89.45 $628,095 - $731,074
8,173 Added 7.16%
122,308 $9.48 Million
Q4 2021

Feb 14, 2022

BUY
$74.57 - $87.19 $96,791 - $113,172
1,298 Added 1.15%
114,135 $9.8 Million
Q3 2021

Nov 08, 2021

SELL
$73.77 - $83.61 $172,843 - $195,898
-2,343 Reduced 2.03%
112,837 $9.08 Million
Q2 2021

Aug 11, 2021

SELL
$80.5 - $88.01 $8.19 Million - $8.96 Million
-101,793 Reduced 46.92%
115,180 $9.27 Million
Q1 2021

May 14, 2021

BUY
$76.38 - $86.03 $2.2 Million - $2.48 Million
28,794 Added 15.3%
216,973 $18.3 Million
Q4 2020

Feb 10, 2021

SELL
$75.39 - $82.36 $260 Million - $284 Million
-3,445,020 Reduced 94.82%
188,179 $15.1 Million
Q3 2020

Nov 13, 2020

BUY
$78.33 - $90.73 $15.5 Million - $17.9 Million
197,361 Added 5.74%
3,633,199 $292 Million
Q2 2020

Aug 13, 2020

BUY
$78.66 - $94.14 $38.5 Million - $46 Million
489,026 Added 16.6%
3,435,838 $296 Million
Q1 2020

May 14, 2020

SELL
$71.57 - $93.3 $45.2 Million - $59 Million
-631,918 Reduced 17.66%
2,946,812 $239 Million
Q4 2019

Feb 13, 2020

BUY
$76.7 - $88.45 $39.5 Million - $45.5 Million
514,729 Added 16.8%
3,578,730 $299 Million
Q3 2019

Nov 14, 2019

SELL
$81.4 - $89.78 $22.3 Million - $24.6 Million
-273,743 Reduced 8.2%
3,064,001 $268 Million
Q2 2019

Aug 14, 2019

BUY
$73.44 - $82.41 $166,635 - $186,988
2,269 Added 0.07%
3,337,744 $273 Million
Q1 2019

May 15, 2019

BUY
$64.48 - $81.31 $2.68 Million - $3.37 Million
41,488 Added 1.26%
3,335,475 $271 Million
Q4 2018

Feb 06, 2019

BUY
$61.45 - $77.8 $34.9 Million - $44.2 Million
567,688 Added 20.82%
3,293,987 $217 Million
Q3 2018

Nov 15, 2018

BUY
$70.71 - $77.75 $8.61 Million - $9.47 Million
121,771 Added 4.68%
2,726,299 $210 Million
Q2 2018

Aug 13, 2018

BUY
$63.43 - $75.41 $132 Million - $157 Million
2,086,527 Added 402.8%
2,604,528 $192 Million
Q1 2018

May 14, 2018

BUY
$62.56 - $72.26 $17.3 Million - $20 Million
277,209 Added 115.12%
518,001 $33.7 Million
Q4 2017

Feb 13, 2018

BUY
$61.45 - $66.05 $1.51 Million - $1.62 Million
24,534 Added 11.34%
240,792 $15.6 Million
Q3 2017

Nov 13, 2017

BUY
$59.5 - $64.61 $5.72 Million - $6.21 Million
96,162 Added 80.07%
216,258 $13.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
120,096
120,096 $7.27 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.